A new anti-marijuana campaign paid for with $2 million in Colorado state tax funds this week drew backlash from the state’s cannabis industry, including University of...
The long and winding path to federal marijuana legalization has tried the patience of many in the cannabis community. Now it seems Wall Street has moved...
Psychedelic drug treatment companies are racing to find a cure for alcohol use disorder or alcoholism. This week, atai Life Sciences gave investors an update on...
Federal regulators approved Johnson & Johnson’s (NYSE: JNJ) nasal spray Spravato as the first stand-alone therapy for adults with treatment-resistant depression. The Food and Drug Administration’s...
As the “debanking” debate roils Washington, cannabis executives – including the CEO of Florida-based Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) Kim Rivers are leveraging political...
Alberta-based Simply Solventless Concentrates Ltd. (TSXV: HASH) announced Tuesday a $5 million convertible debenture financing package, including a $3 million lead investment from institutional investor Plaza...
Protect the People’s Trust, or PPT, a nonprofit that advocates for government transparency, has filed a federal lawsuit under the Freedom of Information Act (FOIA) accusing...
In a bid to play on tech mogul Elon Musk’s new mandate from President Donald Trump to identify places where the federal government can slash spending,...
Parke Bank‘s parent, Parke Bancorp (NASDAQ: PKBK), reported last week that its cannabis-related deposits surged nearly 57% in the fourth quarter, showing signs of recovery as...
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) announced a solid fiscal first quarter of 2025 for the quarter ending November 30, 2024. The Canadian company reported that...